Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 8.77%66.75M | -11.23%128.85M | 36.18%61.37M | 25.48%145.14M | 8.08%45.07M | 129.62%115.67M | 111.08%41.7M | 127.36%50.38M | 175.55%19.75M | -84.47%22.16M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | -28.21%-9.8M | -54.68%-7.64M | -53.01%-7.64M | -28.68%-4.94M | -21.08%-5M | 6.76%-3.84M | ---4.13M | -8.75%-4.12M | ---- | ---3.79M |
| Impairment and provisions: | 359.32%19.15M | -111.17%-14.86M | 112.72%4.17M | 2,446.46%133.02M | -626.11%-32.77M | -109.26%-5.67M | -40.35%6.23M | 43.88%61.19M | -45.16%10.44M | -32.74%42.53M |
| -Other impairments and provisions | 423.50%18.64M | 26.27%-21.35M | 110.86%3.56M | -20.61%-28.96M | -720.00%-32.78M | -166.78%-24.01M | -36.82%5.29M | 7.99%35.95M | -55.63%8.37M | 8,414.20%33.29M |
| Asset sale loss (gain): | 271.64%305.47K | 100.05%262.59K | -85.22%82.19K | -196,750.89%-500.85M | 299.62%556.19K | 38.69%-254.43K | -1,544.86%-278.62K | -554.84%-414.98K | 452.76%19.28K | -90.06%91.24K |
| -Loss (gain) on sale of property, machinery and equipment | 271.64%305.47K | 100.05%262.59K | -85.22%82.19K | -196,750.89%-500.85M | 299.62%556.19K | 38.69%-254.43K | -1,544.86%-278.62K | -554.84%-414.98K | 452.76%19.28K | -90.06%91.24K |
| Depreciation and amortization: | -0.69%67.79M | -10.84%131.6M | -0.77%68.26M | 19.36%147.61M | 47.42%68.8M | 5.46%123.66M | 48.19%46.67M | 77.35%117.26M | -4.98%31.49M | -15.69%66.12M |
| -Amortization of intangible assets | -3.10%5.17M | -48.30%10.62M | 6.71%5.34M | 75.53%20.53M | -28.62%5M | -29.86%11.7M | -16.92%7M | 5.01%16.68M | 11.19%8.43M | 171.45%15.88M |
| -Other depreciation and amortization | --763.47K | --508.98K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial expense | -403.70%-809.13K | -3,701.54%-4.33M | 105.89%266.42K | 99.40%-113.85K | 13.99%-4.53M | -160.54%-19.12M | 42.31%-5.26M | -166.17%-7.34M | -2,544.73%-9.12M | --11.09M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -128.92%-44.42M | 85.79%-97.94M | 146.45%153.62M | -2,454.49%-689.45M | -188.21%-330.7M | 103.80%29.28M | 84.41%-114.75M | -225.30%-771.51M | -175.01%-735.88M | -335.93%-237.17M |
| Accounts receivable (increase)decrease | 35.24%-260.65M | 856.14%265.78M | -71.58%-402.47M | 384.20%27.8M | -66.28%-234.57M | 97.27%-9.78M | 36.44%-141.07M | -1,094.66%-357.8M | -553.87%-221.96M | -112.62%-29.95M |
| Accounts payable increase (decrease) | 22.42%-110.46M | -114.86%-124.07M | -129.76%-142.38M | 493.05%835M | 20.39%478.49M | -141.38%-212.44M | -32.23%397.45M | 387.68%513.37M | 1,509.89%586.5M | 619.61%105.27M |
| Special items of business | -101.10%-203.11K | 183.42%5.54M | -8.38%18.4M | -234.81%-6.64M | 11,683.19%20.08M | 155.14%4.92M | 104.51%170.45K | -149.34%-8.93M | -128.77%-3.78M | --18.09M |
| Adjustment items of business operations | -2.80%-272.14M | 197.89%277.64M | -1,705.89%-264.72M | 432.18%93.2M | -106.47%-14.66M | 104.39%17.51M | 171.08%226.56M | -1,586.87%-398.98M | 0.77%-318.75M | ---23.65M |
| Net cash from operations | -10.57%-272.35M | 227.12%283.18M | -4,639.38%-246.32M | 285.84%86.57M | -97.61%5.43M | 105.50%22.44M | 170.30%226.73M | -7,236.21%-407.91M | -4.69%-322.53M | -102.51%-5.56M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | 41.82%7.64M | ---- | 22.22%5.39M | ---- | 0.00%4.41M | ---- | 0.00%4.41M | ---- | 0.00%4.41M |
| Sale of fixed assets | -99.90%84K | -82.52%46.79M | 102,048.45%84.84M | 40,458.55%267.64M | -81.25%83.06K | -94.78%659.88K | 66.88%442.89K | 23,750.72%12.64M | 465.85%265.4K | -97.48%53K |
| Purchase of fixed assets | 54.56%-5.78M | 4.95%-26.83M | 35.20%-12.71M | 47.88%-28.22M | -269.04%-19.61M | 60.20%-54.14M | -31.80%-5.31M | -116.29%-136.04M | 77.41%-4.03M | 38.60%-62.9M |
| Other items in the investment business | 101.29%3.29M | ---596.6M | ---256M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 98.69%-2.4M | -332.42%-568.99M | -841.46%-183.87M | 598.85%244.81M | -300.89%-19.53M | 58.76%-49.07M | -29.33%-4.87M | -103.63%-118.99M | 78.84%-3.77M | 42.57%-58.43M |
| Net cash before financing | 36.13%-274.75M | -186.25%-285.81M | -2,950.15%-430.19M | 1,343.94%331.37M | -106.36%-14.1M | 94.94%-26.64M | 167.99%221.86M | -723.34%-526.9M | -0.13%-326.3M | -153.40%-64M |
| Cash flow from financing activities | ||||||||||
| Dividends paid - financing | ---- | -20.83%-45.73M | ---- | -148.36%-37.85M | ---- | ---15.24M | ---- | ---- | ---- | 21.06%-60.4M |
| Absorb investment income | ---- | --19.3M | --19.3M | ---- | ---- | --15M | ---- | ---- | ---- | ---- |
| Net cash from financing operations | ---- | 30.16%-26.43M | --19.3M | -15,630.56%-37.85M | ---- | ---240.62K | ---- | ---- | ---- | 21.06%-60.4M |
| Effect of rate | 2.52%1.05M | 84.23%1.7M | -24.06%1.02M | -91.96%924.38K | -82.82%1.35M | 496.06%11.5M | 4,196.13%7.84M | -7,622.84%-2.9M | -524.10%-191.48K | -116.20%-37.58K |
| Net Cash | 33.13%-274.75M | -206.38%-312.24M | -2,813.31%-410.89M | 1,191.99%293.52M | -106.36%-14.1M | 94.90%-26.88M | 167.99%221.86M | -323.55%-526.9M | -0.13%-326.3M | -387.07%-124.4M |
| Begining period cash | -21.31%1.15B | 25.31%1.46B | 25.31%1.46B | -1.31%1.16B | -1.31%1.16B | -31.01%1.18B | -31.01%1.18B | -6.79%1.71B | -6.79%1.71B | 2.43%1.83B |
| Cash at the end | -16.64%873.36M | -21.31%1.15B | -8.92%1.05B | 25.31%1.46B | -18.31%1.15B | -1.31%1.16B | 1.91%1.41B | -31.01%1.18B | -8.30%1.38B | -6.79%1.71B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.